Bioethics News

FDA Takes Steps to Protect Blood Supply in Florida Amid Zika Probe

July 28, 2016

(Reuters) – The U.S. Food and Drug Administration has ordered all blood collection centers in Florida’s Miami-Dade and Broward counties to stop collecting blood as state health department officials continue to investigate four possible cases of local transmission of the Zika virus. In a statement posted on its website on Wednesday, the FDA said blood centers should stop collecting blood in the two counties until they can implement testing for the Zika virus in each unit of blood collected, or until they can put in place technology that can kill pathogens in collected blood.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.